ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis

Completed · Phase 2

Conditions studied: Actinic Keratosis

In brief

The purpose of this study is to determine whether or not ACT01 is effective and tolerable alone or when used in combination with Comp01, Comp02, Comp03 or Comp04 in patients with facial and/or scalp keratosis.

Key facts

Study ID
NCT02126670
Run by
Promius Pharma, LLC
People needed
100
Starts
2014-04-01
Expected to finish
2014-09-01
Last updated by the study team
2016-02-22

Who can join

Age: 30 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.